✦ LIBER ✦

c-kit point mutation of extracellular domain in patients with myeloproliferative disorders

✍ Scribed by Yoshio Nakata; Akiro Kimura; Osamd Katoh; Kuniko Kawaishi; Hideo Hyodo; Kazuhiro Abe; Atsushi Kuramoto; Yukio Satow

Book ID: 114714309
Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 326 KB
Volume: 91
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.1995.tb05364.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lack of c-kit point mutations in patient

Lack of c-kit point mutations in patients with myelodysplastic syndromes and other hematopoietic disorders

✍ Carlos M. deCastro; G.R. Vandenbark; Russel E. Kaufman 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Analysis of JAK2V617F mutation in Chines

Analysis of JAK2V617F mutation in Chinese patients with myeloproliferative disorders

✍ Suning Chen; Hairong Fei; Ri Zhang; Yongquan Xue; Jinlan Pan; Yafang Wu; Jiannon 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Prevalence of the JAK2-V617F mutation in

Prevalence of the JAK2-V617F mutation in Taiwanese patients with chronic myeloproliferative disorders

✍ C.-H. Lieu; H.-S. Wu; Y.-C. Hon; W.-H. Tsai; C.-F. Yang; C.-C. Wang; Y.-C. Lin; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Incidence and significance of theJAK2V61

Incidence and significance of theJAK2V617F mutation in patients with chronic myeloproliferative disorders

✍ S. E. Langabeer; F. Ni Ainle; E. Conneally; M. Lawler 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 166 KB

Correlations of JAK2–V617F mutation with

Correlations of JAK2–V617F mutation with clinical and laboratory findings in patients with myeloproliferative disorders

✍ Matthaios Speletas; Eirini Katodritou; Chrisoula Daiou; Eudokia Mandala; Emmanou 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Recently, the acquired mutation JAK2-V617F has been described in the majority of patients with myeloproliferative disorders (MPDs). In this study we evaluated its clinical and laboratory correlates in 166 patients with MPDs. The mutation was detected by allele-specific PCR in 119 patients: 81.4% (35

Epigenetic alterations complement mutati

Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders

✍ Jost, E; do Ó, N; Dahl, E; Maintz, C E; Jousten, P; Habets, L; Wilop, S; Herman, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 165 KB